The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Lancing Devices And Equipment Market By 2030 Starting From Its 2026 Size?
The lancing devices and equipment market has demonstrated strong growth in recent years. Its valuation is projected to rise from $3.25 billion in 2025 to $3.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.4%. Historically, this expansion has been driven by the increasing prevalence of diabetes, the broadening implementation of self-monitoring blood glucose practices, improved access to disposable medical devices, advancements in lancet safety designs, and the growth of point-of-care diagnostics.
The lancing devices and equipment market is anticipated to show significant expansion in the next few years. It is projected to grow to $4.98 billion in 2030, driven by a compound annual growth rate (CAGR) of 9.1%. This growth during the forecast period can be attributed to several factors, including the increasing demand for home diagnostics solutions, a heightened focus on patient comfort and compliance, the broadening of chronic disease monitoring programs, the rising adoption of minimally invasive sampling devices, and growing investments in personal healthcare technologies. Key trends during this period are expected to involve the increasing embrace of single-use safety lancets, a rising need for pain-minimized sampling devices, the expanding use of home-based glucose monitoring, the development of adjustable depth lancing technologies, and an enhanced emphasis on infection control.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2484&type=smp
What Drivers Are Shaping The Future Growth Of The Lancing Devices And Equipment Market?
The increasing incidence of diabetes is a key factor propelling the expansion of the lancing devices and equipment market. This chronic metabolic condition, characterized by elevated blood glucose levels, necessitates consistent monitoring to effectively manage it and avert complications like neuropathy, cardiovascular disease, and kidney damage. The surge in diabetes cases is primarily attributed to growing obesity rates, which lead to insulin resistance and metabolic dysfunction that contribute to the disease’s onset. This growing prevalence of diabetes thus underpins the lancing devices and equipment sector by heightening the demand for secure, precise, and user-friendly blood sampling instruments that facilitate regular glucose testing, whether at home or in clinical environments. As an illustration, according to The Guardian, a United Kingdom based news organization, a total of 12.2 million people were affected by diabetes or non-diabetic hyperglycaemia in the United Kingdom by February 2025. This figure included 4.6 million with diagnosed diabetes, 1.3 million with undiagnosed diabetes, and 6.3 million with non-diabetic hyperglycaemia, marking an increase from an estimated 12.1 million cases observed between 2023 and 2024. Consequently, the rising prevalence of diabetes is a significant force driving the growth of the lancing devices and equipment market.
Which Segment Categories Define The Lancing Devices And Equipment Market?
The lancing devices and equipment market covered in this report is segmented –
1) By Usage Mode: Reusable, Disposable
2) By Product: Safety Lancets, Standard Lancets
3) By Penetration Depth: 0.8mm-1mm, 1.1mm- 1.5mm, 1.6mm-2.0mm, Other Penetration Depths
4) By End User: Hospitals and Clinics, Homecare and Home Diagnostics, Diagnostic Centres and Medical Institutions, Research and Academic Laboratories, Other End User
Subsegments:
1) By Reusable: Manual Reusable Lancets, Automated Reusable Lancets
2) By Disposable: Pre-filled Disposable Lancets, Single-use Lancets
What Major Market Trends Are Driving Changes In The Lancing Devices And Equipment Market?
Leading companies in the lancing devices and equipment market are creating innovative products, such as disposable lancing devices, to offer a more convenient and comfortable experience for monitoring blood sugar. A disposable lancing device is a small, portable tool designed to prick the skin and gather a tiny blood sample for glucose analysis. For example, in August 2023, F. Hoffmann-La Roche AG, a pharmaceutical company based in Switzerland, unveiled Accu-Chek Pico. This completely disposable lancing device is engineered to simplify and enhance the convenience of blood sugar monitoring for individuals with diabetes, especially older adults. It delivers numerous benefits for diabetic patients, particularly the elderly, being simple to operate, gentle on the skin, offering uniform lancing depths, and being entirely disposable. Additionally, it is compatible with a range of Accu-Chek blood glucose meters, which further eases the process for people with diabetes.
Who Are The Top Companies Competing In The Lancing Devices And Equipment Market?
Major companies operating in the lancing devices and equipment market are Abbott laboratories, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche AG, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Becton Dickinson and Company, Bayer AG, Medtronic plc, ARKRAY Inc., Sanofi S.A., Ypsomed Holding AG, Sarstedt AG & Co., Greiner Bio-One, HTL-STREFA S.A, Guangzhou Improve Medical Instruments Co. Ltd., UltiMed Inc., Allison Medical Inc., Artsana S.p.a., Perrigo Diabetes Care, MedExel Co. Ltd., Simple Diagnostics, Stat Medical Inc., Trividia Health, Eli Lilly and Company, Roche Diagnostics, Terumo Corporation, LifeScan, Dynarex Corporation, Dealmed Medical Supplies LLC, Advanced Diabetic Solutions, Medline Industries Inc., Owen Mumford, ARKRAY USA Inc., Nipro Diagnostics Inc., AgaMatrix Inc., Nova Biomedical, Prodigy Diabetes Care LLC, ACON Laboratories Inc.
Read the full lancing devices and equipment market report here:
https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report
Which Geographic Regions Are Influencing Demand In The Lancing Devices And Equipment Market?
North America was the largest region in the global lancing devices and equipment market in 2025. Western Europe was the second-largest region in the lancing devices and equipment market. The regions covered in the lancing devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Lancing Devices And Equipment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2484&type=smp
Browse Through More Reports Similar to the Global Lancing Devices And Equipment Market 2026, By The Business Research Company
Next Generation Network Equipment Market Report 2026
Telecom Infrastructure Equipment Market Report 2026
Telecom Infrastructure Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model